 |
 |

Researchers Size Up Nanotechnology Risks
Tracy Hampton, PhD
JAMA. 2005;294:1881-1883.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Nanotechnology, a burgeoning field featuring tiny materials, may be poised to transform medicine with potential uses spanning all aspects of disease diagnosis, prevention, and treatment. In oncology alone, researchers envision using nanomaterials (which by definition have at least one dimension ranging from 1 nm [one billionth of a meter] to 100 times that) to detect early cancers, pinpoint tumors within the body, deliver toxic drugs specifically to malignant cells, and determine a therapys effectiveness. Similar medical uses may exist for arthritis, heart disease, and many other conditions.
| |
More research is needed to assess the safety of nanomaterials, novel materials that have at least one dimension that does not exceed 100 nanometers in size. (Image reproduced with permission from Science. 2004;303:348-352.) (Photo credit: AAAS)
|
|
But even if these advances are achievable, little is known about the safety of nanomaterials in medicine or in other applications, such as . . . [Full Text of this Article] LACK OF DATA
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|